tirzepatide vs semaglutide weight loss study for Treatment Tirzepatide Outperforms Semaglutide in Weight
Description
Of note, this approach to ICP monitoring was chosen by the patient advisory group due to the negative impact reported by repeated lumbar punctures [23, 24], and the use within the trial was carefully discussed with the individual participants during the consent process
After eligibility determination, 358 articles were excluded, leaving 26 articles to be used for analysis
When to Increase Your GLP-1 Dose Moving to the next dose level may be the right choice if: Youve been on your current dose for at least 4 weeks This ensures your body has adjusted and experienced the full effects
The medication slows gastric emptying, which can reduce intestinal motility and lead to difficulty with bowel movements within the first few weeks of therapy
10.1111/andr.12966
